A detailed history of Aspen Investment Management Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Aspen Investment Management Inc holds 5,086 shares of ABBV stock, worth $905,358. This represents 0.47% of its overall portfolio holdings.

Number of Shares
5,086
Previous 5,086 -0.0%
Holding current value
$905,358
Previous $872,000 15.14%
% of portfolio
0.47%
Previous 0.44%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 26, 2024

SELL
$154.79 - $180.76 $7,739 - $9,038
-50 Reduced 0.97%
5,086 $872,000
Q1 2024

Apr 26, 2024

BUY
$159.82 - $182.1 $20,776 - $23,673
130 Added 2.6%
5,136 $935,000
Q4 2023

Feb 09, 2024

BUY
$137.6 - $154.97 $137 - $154
1 Added 0.02%
5,006 $776,000
Q4 2022

Feb 06, 2023

SELL
$138.31 - $165.87 $67,771 - $81,276
-490 Reduced 8.92%
5,005 $809,000
Q1 2022

May 11, 2022

BUY
$131.98 - $163.75 $13,197 - $16,375
100 Added 1.85%
5,495 $891,000
Q1 2020

May 15, 2020

SELL
$64.5 - $97.79 $3,225 - $4,889
-50 Reduced 0.92%
5,395 $411,000
Q3 2019

Nov 13, 2019

SELL
$62.98 - $75.72 $3,149 - $3,786
-50 Reduced 0.91%
5,445 $412,000
Q2 2019

Aug 12, 2019

SELL
$65.7 - $83.98 $9,855 - $12,597
-150 Reduced 2.66%
5,495 $400,000
Q2 2018

Aug 14, 2018

BUY
$89.78 - $106.23 $8,978 - $10,623
100 Added 1.8%
5,645 $523,000
Q1 2018

May 16, 2018

BUY
$92.01 - $123.21 $10,121 - $13,553
110 Added 2.02%
5,545 $525,000
Q4 2017

Feb 15, 2018

BUY
$89.56 - $98.21 $20,151 - $22,097
225 Added 4.32%
5,435 $0
Q3 2017

Nov 15, 2017

BUY
$69.85 - $89.22 $363,918 - $464,836
5,210
5,210 $463,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $315B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Aspen Investment Management Inc Portfolio

Follow Aspen Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aspen Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Aspen Investment Management Inc with notifications on news.